XBIT XBiotech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: XBIT

Price (delayed)

$8.21

Market cap

$250M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.81

Enterprise value

$49.98M

XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally ...

Highlights
XBiotech's net income has increased by 25% YoY but it has decreased by 6% from the previous quarter
XBiotech's EPS has increased by 25% YoY but it has decreased by 7% QoQ
XBIT's gross profit has dropped by 100% since the previous quarter and by 100% year-on-year
XBIT's revenue has dropped by 100% since the previous quarter and by 100% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.xbiotech.com
Peers: ENZ QURE AUPH

Key stats

What are the main financial stats of XBIT
Market
Shares outstanding
30.45M
Market cap
$250M
Enterprise value
$49.98M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.14
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$24.31M
EBITDA
-$22.57M
Free cash flow
-$19.09M
Per share
EPS
-$0.81
Free cash flow per share
-$0.63
Book value per share
$7.19
Revenue per share
$0
TBVPS
$7.45
Balance sheet
Total assets
$226.62M
Total liabilities
$7.77M
Debt
$0
Equity
$218.85M
Working capital
$195.62M
Liquidity
Debt to equity
0
Current ratio
33.07
Quick ratio
32.79
Net debt/EBITDA
8.86
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-10.5%
Return on equity
-10.8%
Return on invested capital
-45%
Return on capital employed
-11%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

XBIT stock price

How has the XBiotech stock price performed over time
Intraday
1.73%
1 week
3.79%
1 month
9.61%
1 year
147.29%
YTD
105.25%
QTD
1.99%

Financial performance

How have XBiotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$37.51M
Net income
-$24.56M
Gross margin
N/A
Net margin
N/A
XBIT's gross profit has dropped by 100% since the previous quarter and by 100% year-on-year
XBIT's revenue has dropped by 100% since the previous quarter and by 100% year-on-year
XBiotech's net income has increased by 25% YoY but it has decreased by 6% from the previous quarter
The company's operating income fell by 9% YoY

Growth

What is XBiotech's growth rate over time

Valuation

What is XBiotech stock price valuation
P/E
N/A
P/B
1.14
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
XBiotech's EPS has increased by 25% YoY but it has decreased by 7% QoQ
The P/B is 90% higher than the last 4 quarters average of 0.6 but 19% lower than the 5-year quarterly average of 1.4
The equity has declined by 9% year-on-year
XBIT's revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Efficiency

How efficient is XBiotech business performance
XBIT's ROIC has soared by 60% YoY but it is down by 11% QoQ
The return on equity rose by 18% year-on-year but it has declined by 8% since the previous quarter
XBIT's ROA is up by 17% YoY but it is down by 8% QoQ

Dividends

What is XBIT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XBIT.

Financial health

How did XBiotech financials performed over time
The current ratio has contracted by 39% YoY and by 14% from the previous quarter
XBIT's quick ratio is down by 39% year-on-year and by 14% since the previous quarter
The debt is 100% lower than the equity
The equity has declined by 9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.